mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.09 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.09 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.09 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.09 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.09 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.09 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.09 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.09 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |